- Community-Beiträge
- Aktuellste Threads
| Geld/Brief | 3,81 $ / 4,49 $ |
| Spread | +17,85% |
| Schluss Vortag | 3,94 $ |
| Gehandelte Stücke | 444.289 |
| Tagesvolumen Vortag | 2.284.969 $ |
| Tagestief 3,815 $ Tageshoch 4,145 $ | |
| 52W-Tief 2,94 $ 52W-Hoch 7,54 $ | |
| Jahrestief 2,94 $ Jahreshoch 6,56 $ | |
| Umsatz in Mio. | 44,55 $ |
| Operatives Ergebnis (EBIT) in Mio. | -71,05 $ |
| Jahresüberschuss in Mio. | -83,78 $ |
| Umsatz je Aktie | 0,37 $ |
| Gewinn je Aktie | -0,69 $ |
| Gewinnrendite | -188,09% |
| Umsatzrendite | -188,09% |
| Return on Investment | -52,23% |
| Marktkapitalisierung in Mio. | 516,92 $ |
| KGV (Kurs/Gewinn) | -9,36 |
| KBV (Kurs/Buchwert) | - |
| KUV (Kurs/Umsatz) | 17,46 |
| Eigenkapitalrendite | - |
| Eigenkapitalquote | -20,98% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| AMEX | 4,135 $ | +3,89% | 3,98 $ | 17.07.26 | |
| Nasdaq | 4,125 $ | +4,70% | 3,94 $ | 17.07.26 | |
| NYSE | 4,105 $ | +4,06% | 3,945 $ | 17.07.26 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 17.07.26 | 4,12 | 1,25 M |
| 16.07.26 | 3,94 | 2,28 M |
| 15.07.26 | 3,95 | 0,80 M |
| 14.07.26 | 4,04 | 407 T |
| 13.07.26 | 4,06 | 0,82 M |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 4,12 $ | +0,12% |
| 1 Monat | 4,43 $ | -6,88% |
| 6 Monate | 3,31 $ | +24,62% |
| 1 Jahr | 4,37 $ | -5,61% |
| 5 Jahre | 3,32 $ | +24,25% |
| Marktkapitalisierung | 516,92 Mio. $ |
| Streubesitz | 91,31% |
| Währung | USD |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Medikamente |
| Aktientyp | Stammaktie |
| +8,11% | Bratton Capital Management, L.P. |
| +5,35% | BlackRock Inc |
| +5,12% | RTW INVESTMENTS, LLC |
| +3,58% | Vanguard Group Inc |
| +3,54% | Vanguard Capital Management, LLC |
| +2,46% | Millennium Management LLC |
| +2,15% | EcoR1 Capital, LLC |
| +2,05% | Samsara BioCapital, LLC |
| +1,94% | Vanguard Total Stock Mkt Idx Inv |
| +1,81% | Perceptive Advisors LLC |
| +1,73% | iShares Russell 2000 ETF |
| +1,64% | Federated Hermes Inc |
| +1,63% | Geode Capital Management, LLC |
| +1,39% | Pale Fire Capital SE |
| +1,25% | State Street Corp |
| +1,17% | Morgan Stanley - Brokerage Accounts |
| +1,06% | Bank of America Corp |
| +0,96% | Wells Fargo & Co |
| +0,96% | BNP Paribas Arbitrage, SA |
| +0,92% | Two Sigma Investments LLC |
| +0,87% | Federated Hermes MDT SCC Institutional |
| +0,87% | Federated Hermes MDT Small Cap Core IS |
| +0,87% | Commonwealth Equity Services Inc |
| +0,87% | Janney Montgomery Scott LLC |
| +0,86% | Commonwealth Equity Services, LLC |
| +0,83% | Jane Street Group LLC |
| +0,82% | HRT FINANCIAL LLC |
| +0,80% | Balyasny Asset Management LLC |
| +0,78% | Sio Capital Management, LLC |
| +0,77% | D. E. Shaw & Co LP |
| +0,76% | Blue Owl Capital Holdings LP |
| +0,73% | The Goldman Sachs Group Inc |
| +0,71% | Wasatch Advisors LP |
| +0,71% | Vanguard Institutional Extnd Mkt Idx Tr |
| +0,71% | Fidelity Small Cap Index |
| +0,64% | Barclays PLC |
| +0,57% | Bridge Builder Small/Mid Cap Growth |
| +0,55% | Wasatch Ultra Growth |
| +0,54% | State Street® SPDR® S&P® PhrmctlsETF |
| +0,54% | Everstar Asset Management LLC |
| +0,53% | Russell 2000 Equity Index Fund B |
| +0,53% | Northern Trust Corp |
| +0,47% | State St Russell Sm/Mid Cp® Indx SL Cl I |
| +0,46% | Two Sigma Advisers, LLC |
| +0,43% | Truvalue Glb Phrmctl Blgcl Eq (QDII) A |
| +0,43% | Goldman Sachs Group Inc |
| +0,41% | iShares Russell 2000 Value ETF |
| +0,39% | Susquehanna International Group, LLP |
| +0,38% | Bracebridge Capital, LLC |
| +0,36% | JPMorgan Chase & Co |
| +0,35% | abrdn Healthcare Investors |
| +0,35% | Fidelity Extended Market Index |
| +0,34% | SSgA Russell Small Cap Completeness Idx |
| +0,34% | Vanguard Russell 2000 ETF |
| +0,28% | State St Russell Sm Cap® Idx SL Cl I |
| +0,28% | Federated Hermes MDT Small Cap Growth IS |
| +0,28% | Federated Hermes MDT SCG Institutional |
| +0,22% | Simplify Propel Opportunities ETF |
| +0,21% | State St Russell Sm Cap® Indx SL Cl I |
| +0,21% | iShares Russell 2000 Growth ETF |
| +0,20% | Blackrock Extended Mkt Fund CF |
| +0,20% | Extended Equity Market Fund E |
| +0,18% | Schwab Small Cap Index |
| +0,17% | NT R2000 Index Fund - NL |
| +0,16% | iShares Micro-Cap ETF |
| +0,16% | abrdn Life Sciences Investors |
| +0,14% | NT R2000 Index Fund - DC - NL - 3 |
| +0,13% | iShares Core S&P Total US Stock Mkt ETF |
| +0,13% | Russell 2500™ Index Fund F |
| +0,12% | Extended Equity Market Fund K |
| +0,11% | SPDR® Russell 2000 US Small Cap ETF |
| +0,11% | Fidelity Total Market Index |
| +57,62% | Institutionelle Aktionäre |
| +91,31% | Streubesitz |
| +33,70% | Individuelle Aktionäre |
https://aquestive.com/aquestive-therapeutics-receives-fda-tentative-approval-for-libervant-diazepam-buccal-film/#
Ergebnisse für EPIPHAST Studie (AQST-109)
https://www.benzinga.com/general/biotech/22/06/27735528/aquestive-therapeutics-shares-jump-on-favorable-data-from-epinephrine-trial-for-allergies
Zahlen für Q1/22
https://aquestive.com/aquestive-therapeutics-reports-first-quarter-2022-financial-results-and-provides-business-update/#
Zumindest die MK sieht mittlerweile realistischer aus.
